4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Sai Parenteral's Limited (SAIPARENT) operates in the Drug Manufacturers - General industry and is headquartered in Hyderabad, India with about 293 employees. Its market capitalization is roughly ₹23 billion. In the fiscal year ended 2025-03-31, SAIPARENT reported ₹4.9B in revenue and ₹196M in net income.
Sai Parenteral's Limited, a pharmaceutical formulations company, engages in the branded generic formulations and contract development and manufacturing businesses in India and internationally.
Interactive charts & full statements →
| Income statement | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|
| Total Revenue | ₹4.9B | ₹1.5B | ₹968M |
| Gross Profit | ₹2.2B | ₹588M | ₹388M |
| Operating Income (EBIT) | ₹316M | ₹258M | ₹167M |
| Net Income | ₹196M | ₹84M | ₹44M |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
| Total Revenue | ₹1.8B | ₹2.7B | ₹334M |
| Gross Profit | ₹724M | ₹1.1B | ₹115M |
| Operating Income (EBIT) | ₹154M | ₹143M | ₹33M |
| Net Income | ₹158M | (₹12M) | ₹28M |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|
| Total Assets | ₹7.2B | ₹2.7B | ₹1.3B |
| Total Liabilities | ₹6.0B | ₹1.9B | ₹1.0B |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SAIPARENT viewer.
About TickerBase · Data methodology & sources · Privacy · Terms